PDL third quarter revenue decreases 3% to $83 million
PDL BioPharma, Inc. today announced revenue guidance for the third quarter ending September 30, 2011, of approximately $83 million, as compared with actual results of $86 million for the third quarter of 2010, a three percent decrease.
Linear Mode
